iSpecimen Inc (ISPC)
4.34
-0.24
(-5.24%)
USD |
NASDAQ |
Nov 22, 16:00
4.34
0.00 (0.00%)
After-Hours: 19:49
iSpecimen Shareholders Equity (Quarterly): 4.715M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 4.715M |
| June 30, 2024 | 6.089M |
| March 31, 2024 | 6.813M |
| December 31, 2023 | 9.741M |
| September 30, 2023 | 12.71M |
| June 30, 2023 | 14.71M |
| March 31, 2023 | 18.08M |
| December 31, 2022 | 20.31M |
| September 30, 2022 | 22.42M |
| Date | Value |
|---|---|
| June 30, 2022 | 25.30M |
| March 31, 2022 | 27.67M |
| December 31, 2021 | 29.79M |
| September 30, 2021 | 12.09M |
| June 30, 2021 | 10.68M |
| March 31, 2021 | -31.22M |
| December 31, 2020 | -27.28M |
| September 30, 2020 | -25.70M |
| December 31, 2019 | -22.72M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-31.22M
Minimum
Mar 2021
29.79M
Maximum
Dec 2021
6.345M
Average
11.39M
Median
Shareholders Equity (Quarterly) Benchmarks
| RadNet Inc | 895.31M |
| 23andMe Holding Co | 101.93M |
| Delcath Systems Inc | 8.571M |
| CytoSorbents Corp | 13.00M |
| Progyny Inc | 434.88M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 11.26M |
| Total Liabilities (Quarterly) | 6.550M |
| Debt to Equity Ratio | 0.1834 |
| Current Ratio | 0.7431 |
| Net Debt Paydown Yield | -4.43% |